BioCardia Stock (NASDAQ: BCDA) stock price, news, charts, stock research, profile.
Open | $2.70 |
Close | $2.84 |
Volume / Avg. | 18.08K / 154.94K |
Day Range | 2.70 - 2.88 |
52 Wk Range | 2.62 - 34.80 |
Market Cap | $4.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 3.04% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.
Other companies in BioCardia’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX) and Genprex (NASDAQ:GNPX).
There is no analysis for BioCardia.
BioCardia has a consensus price target of $4.00.
The stock price for BioCardia (NASDAQ: BCDA) is $2.6987 last updated July 23, 2024 at 7:00 AM EDT.
There are no upcoming dividends for BioCardia.
BioCardia’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for BioCardia.
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.